178 related articles for article (PubMed ID: 16551737)
1. Ribonucleic acid interference targeting S100A4 (Mts1) suppresses tumor growth and metastasis of anaplastic thyroid carcinoma in a mouse model.
Shi Y; Zou M; Collison K; Baitei EY; Al-Makhalafi Z; Farid NR; Al-Mohanna FA
J Clin Endocrinol Metab; 2006 Jun; 91(6):2373-9. PubMed ID: 16551737
[TBL] [Abstract][Full Text] [Related]
2. S100A4 silencing suppresses proliferation, angiogenesis and invasion of thyroid cancer cells through downregulation of MMP-9 and VEGF.
Jia W; Gao XJ; Zhang ZD; Yang ZX; Zhang G
Eur Rev Med Pharmacol Sci; 2013 Jun; 17(11):1495-508. PubMed ID: 23771538
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of S100A4 blocks growth and metastasis of anaplastic thyroid cancer cells in vitro and in vivo.
Zhang K; Yu M; Hao F; Dong A; Chen D
Cancer Biomark; 2016 Sep; 17(3):281-291. PubMed ID: 27802204
[TBL] [Abstract][Full Text] [Related]
4. Microarray analysis of metastasis-associated gene expression profiling in a murine model of thyroid carcinoma pulmonary metastasis: identification of S100A4 (Mts1) gene overexpression as a poor prognostic marker for thyroid carcinoma.
Zou M; Famulski KS; Parhar RS; Baitei E; Al-Mohanna FA; Farid NR; Shi Y
J Clin Endocrinol Metab; 2004 Dec; 89(12):6146-54. PubMed ID: 15579771
[TBL] [Abstract][Full Text] [Related]
5. RNA interference targeting inhibition of S100A4 suppresses cell growth and promotes apoptosis in human laryngeal carcinoma Hep‑2 cells.
Liu J; Fu S; Xu Y; Zheng Z
Mol Med Rep; 2014 Sep; 10(3):1389-94. PubMed ID: 24969174
[TBL] [Abstract][Full Text] [Related]
6. Short hairpin RNA-mediated inhibition of S100A4 promotes apoptosis and suppresses proliferation of BGC823 gastric cancer cells in vitro and in vivo.
Hua J; Chen D; Fu H; Zhang R; Shen W; Liu S; Sun K; Sun X
Cancer Lett; 2010 Jun; 292(1):41-7. PubMed ID: 19945782
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid 2 receptor induction by IL-12 and its potential as a therapeutic target for the treatment of anaplastic thyroid carcinoma.
Shi Y; Zou M; Baitei EY; Alzahrani AS; Parhar RS; Al-Makhalafi Z; Al-Mohanna FA
Cancer Gene Ther; 2008 Feb; 15(2):101-7. PubMed ID: 18197164
[TBL] [Abstract][Full Text] [Related]
8. Combined RNA interference of hexokinase II and (131)I-sodium iodide symporter gene therapy for anaplastic thyroid carcinoma.
Kim JE; Ahn BC; Hwang MH; Jeon YH; Jeong SY; Lee SW; Lee J
J Nucl Med; 2011 Nov; 52(11):1756-63. PubMed ID: 21994409
[TBL] [Abstract][Full Text] [Related]
9. S100A4 (Mts1) gene overexpression is associated with invasion and metastasis of papillary thyroid carcinoma.
Zou M; Al-Baradie RS; Al-Hindi H; Farid NR; Shi Y
Br J Cancer; 2005 Nov; 93(11):1277-84. PubMed ID: 16265347
[TBL] [Abstract][Full Text] [Related]
10. Relaxin enhances S100A4 and promotes growth of human thyroid carcinoma cell xenografts.
Radestock Y; Willing C; Kehlen A; Hoang-Vu C; Hombach-Klonisch S
Mol Cancer Res; 2010 Apr; 8(4):494-506. PubMed ID: 20332215
[TBL] [Abstract][Full Text] [Related]
11. RNA interference suppression of A100A4 reduces the growth and metastatic phenotype of human renal cancer cells via NF-kB-dependent MMP-2 and bcl-2 pathway.
Yang XC; Wang X; Luo L; Dong DH; Yu QC; Wang XS; Zhao K
Eur Rev Med Pharmacol Sci; 2013 Jun; 17(12):1669-80. PubMed ID: 23832737
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy of anaplastic thyroid carcinoma with a single-chain interleukin-12 fusion protein.
Shi Y; Parhar RS; Zou M; Baitei E; Kessie G; Farid NR; Alzahrani A; Al-Mohanna FA
Hum Gene Ther; 2003 Dec; 14(18):1741-51. PubMed ID: 14670125
[TBL] [Abstract][Full Text] [Related]
13. RNA interference targeting against S100A4 suppresses cell growth and motility and induces apoptosis in human pancreatic cancer cells.
Tabata T; Tsukamoto N; Fooladi AA; Yamanaka S; Furukawa T; Ishida M; Sato D; Gu Z; Nagase H; Egawa S; Sunamura M; Horii A
Biochem Biophys Res Commun; 2009 Dec; 390(3):475-80. PubMed ID: 19799859
[TBL] [Abstract][Full Text] [Related]
14. S100A4 mRNA as a prognostic marker and therapeutic target in Wilms tumor (WT).
Li HJ; Chen YX; Wang Q; Zhang YG
Eur Rev Med Pharmacol Sci; 2014; 18(6):817-27. PubMed ID: 24706305
[TBL] [Abstract][Full Text] [Related]
15. Restoration of S100A4 expression enhances invasive and metastatic potentials of COLO16 cutaneous squamous cancer cells.
Yu LJ; Li Y; Li C; Li H; Wu ML; Liu ZL; Kong QY; Chen XY; Liu XY; An LJ; Liu J
Cancer Biomark; 2014; 14(5):325-33. PubMed ID: 25171474
[TBL] [Abstract][Full Text] [Related]
16. Systemic shRNA mediated knock down of S100A4 in colorectal cancer xenografted mice reduces metastasis formation.
Dahlmann M; Sack U; Herrmann P; Lemm M; Fichtner I; Schlag PM; Stein U
Oncotarget; 2012 Aug; 3(8):783-97. PubMed ID: 22878175
[TBL] [Abstract][Full Text] [Related]
17. Clusterin promotes growth and invasion of clear cell renal carcinoma cell by upregulation of S100A4 expression.
Liu Y; Men C; Xu Y; Zhao K; Luo L; Dong D; Yu Q
Cancer Biomark; 2018; 21(4):915-923. PubMed ID: 29400663
[TBL] [Abstract][Full Text] [Related]
18. S100A4-neutralizing antibody suppresses spontaneous tumor progression, pre-metastatic niche formation and alters T-cell polarization balance.
Grum-Schwensen B; Klingelhöfer J; Beck M; Bonefeld CM; Hamerlik P; Guldberg P; Grigorian M; Lukanidin E; Ambartsumian N
BMC Cancer; 2015 Feb; 15():44. PubMed ID: 25884510
[TBL] [Abstract][Full Text] [Related]
19. Integrin (alpha6beta4) signals through Src to increase expression of S100A4, a metastasis-promoting factor: implications for cancer cell invasion.
Kim TH; Kim HI; Soung YH; Shaw LA; Chung J
Mol Cancer Res; 2009 Oct; 7(10):1605-12. PubMed ID: 19808905
[TBL] [Abstract][Full Text] [Related]
20. Low-Dose Paclitaxel Reduces S100A4 Nuclear Import to Inhibit Invasion and Hematogenous Metastasis of Cholangiocarcinoma.
Cadamuro M; Spagnuolo G; Sambado L; Indraccolo S; Nardo G; Rosato A; Brivio S; Caslini C; Stecca T; Massani M; Bassi N; Novelli E; Spirli C; Fabris L; Strazzabosco M
Cancer Res; 2016 Aug; 76(16):4775-84. PubMed ID: 27328733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
